Cerebral amyloid angiopathy;Angiopathie amyloïde cérébrale

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 5, Issue 1, 2007, Pages 35-45

  Laly, Florian ^a   Duveau, Jean Paul ^a   Behar, Frédéric ^a   Veysseyre, Anne Marie ^a   Palisson, Muriel ^a  

^a Groupe Hospitalier Joffre Dupuytren   (France)

Author keywords

Cerebral amyloid angiopathy; Cerebral haemorrhage; Dementia; Diagnostic criteria

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN BIOPSY; BRAIN HEMATOMA; DEMENTIA; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS;

AGE FACTORS; AGED; AMYLOID BETA-PROTEIN; BIOPSY; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGES;

EID: 34247185357     PISSN: 17601703     EISSN: None     Source Type: Journal    
DOI: 10.1684/pnv.2007.0038     Document Type: Review

References (54)

1. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, et al. Cerebral amyloid angiopathies : a pathologic, biochemical, and genetic view. J Neuropathol Exp Neuro 2003 ; 62 : 885-98.
2. Salama J, Gherardi R, Amiel H, Poirier J, Delaporte P, Gray F. Post-anoxic delayed encephalopathy with leukoencephalopathy and non-hemorrhagic cerebral amyloid angiopathy. Clin Neuropathol 1986 ; 5 : 153-6.
3. Xu D, Yang CH, Wang LN. Prevalence and characteristics of cerebral amyloid angiopathy in the elderly. Zhonghua Nei Ke Za Zhi 2003 ; 42 : 541-4.
4. Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy : incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983 ; 14 : 915-23.
5. Stam FC, Wigboldus JM, Smeulders AW. Age incidence of senile brain amyloidosis. Pathol Res Pract 1986 ; 181 : 558-62.
6. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987 ; 234 : 371-6.
7. Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988 ; 19 : 205-10.
8. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson Jr EP. Cerebral amyloid angiopathy without and with cerebral hemorrhages : a comparative histological study. Ann Neurol 1991 ; 30 : 637-49.
9. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999 ; 58 : 376-88.
10. Jellinger K. Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol 1977 ; 214 : 195-206.
11. Miras Parra FJ, Valverde Romera M, Gomez Jimenez FJ, de la Higuera Torres-Puchol J, Cantero Hinojosa J, Sanchez Parera R. Amyloid angiopathy as a clinico-pathological entity to consider in the differential diagnosis of any hemorrhagic cerebrovascular accident. Med Interna 1996 ; 13 : 261-4.
12. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 2002 ; 977 : 37-44.
13. Greenberg SM. Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc Dis 2002 ; 13 : 42-7.
14. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 2003 ; 61 : 199-205.
15. Holtzman DM. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 2004 ; 23 : 247-54.
16. Leclercq PD, Murray LS, Smith C, Graham DI, Nicoli JA, Gentleman SM. Cerebral amyloid angiopathy in traumatic brain injury : association with apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 2005 ; 76 : 229-33.
17. Walker LC, Pahnke J, Madauss M, Vogelgesang S, Pahnke A, Herbst EW, et al. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly. Acta Neuropathol (Berl) 2000 ; 100 : 36-42.
18. Garcia C, Pinho e Melo T, Rocha L, Lechner MC. Cerebral hemorrhage and apoE. J Neurol 1999 ; 246 : 830-4.
19. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy : accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998 ; 57 : 353-9.
20. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999 ; 58 : 711-8.
21. Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy : a genetic and pathologic study. Neurology 2000 ; 55 : 947-51.
22. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998 ; 50 : 961-5.
23. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000 ; 342 : 240-5.
24. Ohtani R, Kazui S, Tomimoto H, Minematsu K, Naritomi H. Clinical and radiographic features of lobar cerebral hemorrhage : hypertensive versus non-hypertensive cases. Intern Med 2003 ; 42 : 576-80.
25. Jankowicz E, Drozdowski W. Cerebral amyloid angiopathy as a cause of strokes. Neurol Neurochir Pol 2003 ; 37 : 397-407.
26. Zhan RY, Tong Y, Shen JF, Lang E, Preul C, Hempelmann RG, et al. Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang Univ Sci 2004 ; 5 : 1262-9.
27. Masson C, Leys D, Buée L. Cerebral amyloid angiopathies. Presse Med 2000 ; 29 : 1717-22.
28. Passero S, Burgalassi L, D'Andrea P, Battistini N. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995 ; 26 : 1189-92.
29. Gonzalez-Duarte A, Cantu C, Ruiz-Sandoval JL, Barinagarrementeria F. Recurrent primary cerebral hemorrhage : frequency, mechanisms, and prognosis. Stroke 1998 ; 29 : 1802-5.
30. Neau JP, Ingrand P, Couderq C, Rosier MP, Bailbe M, Dumas P, et al. Recurrent intracerebral hemorrhage. Neurology 1997 ; 49 : 106-13.
31. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001 ; 50 : 765-72.
32. Sarazin M, Amarenco P, Mikol J, Dimitri D, Lot G, Bousser MG. Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia. Eur J Neurol 2002 ; 9 : 353-8.
33. Rensink AA, de Waal RM, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 2003 ; 43 : 207-23.
34. Greenberg SM, Cho HS, O'Donnell HC, Rosand J, Segal AZ, Younkin LH, et al. Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy. Ann N Y Acad Sci 2000 ; 903 : 144-9.
35. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, et al. Plasma beta amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006 ; 66 : 23-9.
36. Welter F, Buttner T, Schumacher S, Mariss G. Cranial magnetic resonance tomography value in diagnosis of dementia. Important additional information for differential diagnosis. Fortschr Med 1996 ; 114 : 451-5.
37. Bell-McGinty S, Lopez OL, Meltzer CC, Scanlon JM, Whyte EM, Dekosky ST, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005 ; 62 : 1393-7.
38. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2-weighted MR images in patients with spontaneous intracerebral hemorrhage : evidence of microangiopathy-related microbleeds. Am J Neuroradiol 1999 ; 20 : 637-42.
39. Imaizumi T, Horita Y, Chiba M, Miyata K, Toyama K, Yoshifuji K, et al. Dot-like hemosiderin spots on gradient echo T2-weighted magnetic resonance imaging are associated with past history of small vessel disease in patients with intracerebral hemorrhage. J Neuroimaging 2004 ; 14 : 251-7.
40. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004 ; 35 : 1415-20.
41. Imaizumi T, Horita Y, Hashimoto Y, Niwa J. Dotlike hemosiderin spots on T2-weighted magnetic resonance imaging as a predictor of stroke recurrence : a prospective study. J Neurosurg 2004 ; 101 : 915-20.
42. Caulo M, Tampieri D, Brassard R, Christine Guiot M, Melanson D. Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy : neuropathologic and neuroradiologic manifestations in one case. Am J Neuroradiol 2001 ; 22 : 1072-6.
43. Peysson S, Nighoghossian N, Derex L, Jouvet A, Hermier M, Trouillas P. Cerebral amyloid angiopathy revealed by transient ischemic events : contribution of MRI to diagnosis and pathophysiology study. Rev Neurol (Paris) 2003 ; 159 : 203-5.
44. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004 ; 55 : 306-19.
45. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 2004 ; 3 : 519-27.
46. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2-weighted MR microscopic images. NMR Biomed 2002 ; 15 : 197-203.
47. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003 ; 50 : 293-302.
48. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC. 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 2005 ; 8 : 527-33.
49. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999 ; 96 : 14079-84.
50. Jack Jr CR, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004 ; 52 : 1263-71.
51. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 2005 ; 53 : 607-13.
52. Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997 ; 28 : 1418-22.
53. Izumihara A, Ishihara T, Iwamoto N, Yamashita K, Ito H. Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 1999 ; 30 : 29-33.
54. Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy : validation of the Boston criteria. Curr Atheroscler Rep 2003 ; 5 : 260-6.